Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

Boston-based biotech firm Manifold Bio announced on Monday that it will partner with Swiss pharmaceutical giant Roche to develop a drug for neurological disease using technology driven by artificial ...

Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...

Tissue engineering has brought revolutionary potential to the regenerative repair of damaged tissues, providing innovative solutions to restore function.

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

From CRISPR to gene banking, synthetic biology has big implications for wildlife evolution and conservation, but ethical ...

The University of California, Irvine has licensed a new cancer-fighting immunotherapy to biotech firm GlyTR Therapeutics Inc. for commercialization, paving the way for what researchers call a ...

Biotech at Hub101! October 27, 2025 Hub101 presented a panel of speakers to discuss the growing biotech industry in the region. The SOM held three Masterclasses during Homecoming for CLU alumni ...

SINGAPORE, SG / ACCESS Newswire / October 22, 2025 / Immortal Dragons, a $40 million longevity fund, announced its strategic ...

For decades, Larsen & Toubro has been the default name for everything that needed to be built in India, from airports and refineries to metros. Its rise from a mid-sized contractor to an engineering ...

Orlando: The federal student loan program debacle has turned into a financial nightmare for many college students. A loan that might have originated at $30,000 could over time have a balance of two to ...